4//SEC Filing
STEMCELLS INC 4
Accession 0001209191-15-003523
$MBOTCIK 0000883975operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:09 PM ET
Size
9.1 KB
Accession
0001209191-15-003523
Insider Transaction Report
Form 4
STEMCELLS INCSTEM
TSUKAMOTO ANN
EVP, Research and Development
Transactions
- Award
Common Stock
2015-01-08+250,000→ 627,506 total - Award
Common Stock
2015-01-08+100,000→ 727,506 total
Holdings
- 3,643(indirect: By Trust)
Common Stock
- 26,490(indirect: By 401(k))
Common Stock
Footnotes (6)
- [F1]Restricted stock units, with 1/3 vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018.
- [F2]Includes (1) 210,000 restricted stock units, with 70,000 of these vesting on each of June 6, 2015, June 6, 2026, and June 6, 2017; (2) 43,333 restricted stock units vesting on January 27, 2015; and (3) 250,000 restricted stock units, with 83,333 of these vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018.
- [F3]Restricted stock units, with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical studies in dry AMD and spinal cord injury.
- [F4]Includes (1) 210,000 restricted stock units, with 70,000 of these vesting on each of June 6, 2015, June 6, 2026, and June 6, 2017; (2) 43,333 restricted stock units vesting on January 27, 2015; (3) 250,000 restricted stock units, with 83,333 of these vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018; and (4) 100,000 restricted stock units with performance based vesting.
- [F5]2,284 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
- [F6]Shares held in 401(k) account in accordance with issuer's employer-match policies.
Documents
Issuer
STEMCELLS INC
CIK 0000883975
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000883975
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:09 PM ET
- Size
- 9.1 KB